InvestorsHub Logo
Followers 51
Posts 8999
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Tuesday, 07/12/2022 8:31:32 AM

Tuesday, July 12, 2022 8:31:32 AM

Post# of 13330
MODERNA ANNOUNCES FIRST PARTICIPANT DOSED IN A PHASE 1 TRIAL OF ITS NIPAH VIRUS MRNA VACCINE, MRNA-1215


NiV is a zoonotic virus, meaning that it can spread between animals and people. The virus can be transmitted to humans from infected animals, through consumption of contaminated food, or directly from other infected persons. NiV is a deadly pathogen that can cause rapidly progressive illness, including acute respiratory infection and encephalitis that can lead to a coma or death. While it is possible to recover, an estimated 40% to 75% of people infected with NiV die as a result of infection.

https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-First-Participant-Dosed-in-a-Phase-1-Trial-of-its-Nipah-Virus-mRNA-Vaccine-mRNA-1215/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News